Hasil Filter

14063

Total database: 17430
Struktur (SMILES)
10481 (74.5%)
Target
8038 (57.2%)
Genomik
107 (0.8%)
Referensi
14063 (100.0%)

Tipe Molekul

Distribusi Wujud Zat

Status Regulasi

Hasil Pencarian (14063)

Halaman 194 / 282
Nalidixic acid Approved DB00779
small molecule | CAS: 389-08-2

Nalidixic acid is a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum. It is an inhibitor of the A subunit of bacterial DNA gyrase.

Kategori:
4-QuinolonesAgents that reduce seizure thresholdAnti-Bacterial Agents +19
Target Protein:
DNADNA topoisomerase 2-betaDNA topoisomerase 2-alpha
Waktu Paruh1.1 to 2.5 hours in…
Vol. Distribusi-
Klirens-
Genetik -
Nalmefene Approved DB06230
small molecule | CAS: 55096-26-9

Nalmefene, a 6-methylene analogue of [naltrexone], is an opioid receptor antagonist.[L40684] It acts as an antagonist at the mu (?)-opioid and delta (?)-opioid receptors and a partial agonist at the kappa (?)-opioid receptor.[L1024] In Europe, nalmefene or…

Kategori:
AlkaloidsAntidotesAntipruritics +18
Target Protein:
Kappa-type opioid receptorDelta-type opioid receptorMu-type opioid receptor
Waktu ParuhThe terminal half-l…
Vol. DistribusiFollowing a 1 mg pa…
KlirensThe oral clearance …
Genetik -
Nalorphine DB11490
small molecule | CAS: 62-67-9

Nalorphine is a mixed opioid agonist–antagonist. It acts at two opioid receptors—at the mu receptor it has antagonistic effects, and at the kappa receptors it exerts high-efficacy agonistic characteristics. It is used to reverse opioid overdose and (starting …

Kategori:
AlkaloidsAntidotesCentral Nervous System Agents +10
Target Protein:
Kappa-type opioid receptor
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Naloxegol Approved DB09049
small molecule | CAS: 854601-70-0

Naloxegol, for "PEGylated naloxol" is a peripherally-selective opioid antagonist developed by AstraZeneca. It was approved by the FDA in September 2014 and is indicated for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non?…

Kategori:
AlcoholsAlimentary Tract and MetabolismAlkaloids +24
Target Protein:
Mu-type opioid receptor
Waktu Paruh6-11 hours.
Vol. Distribusi968 to 2140 L.
KlirensFeces (68%), urine …
Genetik -
Naloxone Approved DB01183
small molecule | CAS: 465-65-6

Naloxone is an opioid antagonist medication used to block or reverse the effects of opioid drugs, particularly within the setting of drug overdoses which are rapidly becoming a leading cause of death worldwide.[A234594] More specifically, naloxone has a high …

Kategori:
Alimentary Tract and MetabolismAlkaloidsAnalgesics +27
Target Protein:
Mu-type opioid receptorDelta-type opioid receptorKappa-type opioid receptor +4
Waktu ParuhThe mean half life …
Vol. DistribusiThe volume of distr…
KlirensThe clearance of na…
Genetik -
small molecule | CAS: 133397-81-6

Deskripsi belum tersedia.

Target Protein:
Serine protease 1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
small molecule

Deskripsi belum tersedia.

Target Protein:
Replicase polyprotein 1abReplicase polyprotein 1a
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Naluzotan DB05562
small molecule | CAS: 740873-06-7

Deskripsi belum tersedia.

Kategori:
Agents that produce hypertensionAmidesAntidepressive Agents +7
Target Protein:
5-hydroxytryptamine receptor 1A
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
small molecule

Deskripsi belum tersedia.

Target Protein:
Pol polyprotein
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Namilumab DB13037
biotech | CAS: 1206681-39-1

Namilumab has been used in trials studying the treatment of Plaque Psoriasis and Rheumatoid Arthritis.

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntibodies, Monoclonal +6
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Namitecan DB12124
small molecule | CAS: 372105-27-6

Namitecan has been used in trials studying the treatment of Solid Tumors.

Kategori:
AlkaloidsAntineoplastic AgentsAntineoplastic Agents, Phytogenic
Target Protein:
DNA topoisomerase 1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Namn DB02382
small molecule

Deskripsi belum tersedia.

Target Protein:
Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferaseNicotinate-nucleotide pyrophosphorylase [carboxylating]
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Namodenoson DB12885
small molecule | CAS: 163042-96-4

Namodenoson has been used in trials studying the treatment of Chronic Hepatitis C and Hepatocellular Carcinoma.

Kategori:
Heterocyclic Compounds, Fused-RingNeurotransmitter AgentsNucleic Acids, Nucleotides, and Nucleosides +7
Target Protein:
Adenosine receptor A3
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Nanatinostat DB15419
small molecule | CAS: 1256448-47-1

Nanatinostat is under investigation in clinical trial NCT00697879 (Safety Study of the Histone Deacetylase Inhibitor, CHR-3996, in Patients With Advanced Solid Tumours).

Kategori:
Antineoplastic AgentsAza CompoundsHistone Deacetylase Inhibitors
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Nandrolone DB13169
small molecule | CAS: 434-22-0

Nandrolone, also known as 19-nortestosterone or 19-norandrostenolone, is a synthetic anabolic-androgenic steroid (AAS) derived from testosterone.

Kategori:
Alimentary Tract and MetabolismAnabolic AgentsAnabolic Agents for Systemic Use +16
Target Protein:
Androgen receptor
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Nandrolone decanoate Approved DB08804
small molecule | CAS: 360-70-3

Nandrolone decanoate, also known as nandrolone caprinate, is an alkylated anabolic steroid indicated in the management of anemia of renal insufficiency and as an adjunct therapy in the treatment of senile and postmenopausal osteoporosis.[A233789,A233849,L3256…

Kategori:
Anabolic AgentsAndrogensBone Density Conservation Agents +16
Target Protein:
Androgen receptorProtein c-Fos5-hydroxytryptamine 2 receptor +3
Waktu ParuhNandrolone decanoat…
Vol. Distribusi-
Klirens50 mg, 100 mg, and …
Genetik -
small molecule | CAS: 98804-55-8

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Nandrolone phenpropionate Approved DB00984
small molecule | CAS: 62-90-8

C18 steroid with androgenic and anabolic properties. It is generally prepared from alkyl ethers of estradiol to resemble testosterone but less one carbon at the 19 position. It is a schedule III drug in the U.S.

Kategori:
Anabolic AgentsAndrogensEstranes +10
Target Protein:
Androgen receptor
Waktu ParuhThe elimination hal…
Vol. Distribusi-
Klirens-
Genetik -
Nangibotide DB16247
biotech | CAS: 2014384-91-7

Nangibotide is under investigation in clinical trial NCT04055909 (Efficacy, Safety and Tolerability of Nangibotide in Patients With Septic Shock).

Kategori:
Amino Acids, Peptides, and ProteinsAnti-Inflammatory AgentsFatty Acids +4
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
small molecule

Nanoparticle Epirubicin is under investigation in clinical trial NCT03168061 (Dose-escalation and Expansion Trial of NC-6300 in Patients With Advanced Solid Tumors or Soft Tissue Sarcoma). It is a novel [epirubicin] drug-conjugated polymeric micelle.

Kategori:
Amino Acids, Peptides, and ProteinsAminoglycoside AntibacterialsAnthracyclines +5
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Nanvuranlat DB18250
small molecule | CAS: 1037592-40-7

Deskripsi belum tersedia.

Kategori:
Amino AcidsAmino Acids, AromaticAmino Acids, Cyclic +2
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
NAP-226-90 DB04556
small molecule | CAS: 139306-10-8

Deskripsi belum tersedia.

Kategori:
AminesBenzene DerivativesEthylamines
Target Protein:
Acetylcholinesterase
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Napabucasin DB12155
small molecule | CAS: 83280-65-3

Napabucasin has been investigated for the treatment of Colorectal Carcinoma.

Kategori:
Heterocyclic Compounds, Fused-RingNaphthalenesQuinones
Target Protein:
Signal transducer and activator of transcription 3
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Naphazoline Approved DB06711
small molecule | CAS: 835-31-4

Naphazoline is a rapid acting imidazoline sympathomimetic vasoconstrictor of ocular or nasal artierioles[L5804,L5807]. It acts to decrease congestion and is found in many over the counter (OTC) eye drops and nasal preparations[L5804,L5807]. Naphazoline was…

Kategori:
Adrenergic AgentsAdrenergic AgonistsAdrenergic alpha-1 Receptor Agonists +17
Target Protein:
D(2) dopamine receptorAlpha-2A adrenergic receptorAlpha-1A adrenergic receptor
Waktu ParuhHalf life has not b…
Vol. DistribusiDistribution data f…
KlirensClearance data for …
Genetik -
small molecule

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
small molecule | CAS: 581-75-9

Deskripsi belum tersedia.

Kategori:
ArylsulfonatesArylsulfonic AcidsNaphthalenes +3
Target Protein:
Bacterioferritin comigratory proteinL-lactate dehydrogenase
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Naphthoquine DB16249
small molecule | CAS: 173531-57-2

Naphthoquine is under investigation in clinical trial NCT01930331 (Safety, Tolerability, Pharmacokinetics and Efficacy of ARCO).

Kategori:
AminesAntimalarialsAntiparasitic Products, Insecticides and Repellents +4
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Naporafenib DB18865
small molecule | CAS: 1800398-38-2

Naporafenib is under investigation in clinical trial NCT06346067 (A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With Nras-mutant Melanoma (SEACRAFT-2)).

Kategori:
AminesAntineoplastic AgentsEnzyme Inhibitors +2
Target Protein:
RAF proto-oncogene serine/threonine-protein kinase
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Naproxcinod DB06682
small molecule | CAS: 163133-43-5

Deskripsi belum tersedia.

Kategori:
Antiinflammatory and Antirheumatic ProductsAntiinflammatory and Antirheumatic Products, Non-SteroidsCardiovascular Agents +5
Target Protein:
Prostaglandin G/H synthase 1Prostaglandin G/H synthase 2
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Naproxen Approved DB00788
small molecule | CAS: 22204-53-1

Naproxen is classified as a nonsteroidal anti-inflammatory dug (NSAID) and was initially approved for prescription use in 1976 and then for over-the-counter (OTC) use in 1994.[A178975] It can effectively manage acute pain as well as pain related to rheumatic …

Kategori:
Agents causing hyperkalemiaAgents that produce hypertensionAnalgesics +41
Target Protein:
Pancreatic triacylglycerol lipaseProstaglandin G/H synthase 1Prostaglandin G/H synthase 2 +1
Waktu ParuhThe elimination hal…
Vol. DistribusiNaproxen has a volu…
KlirensNaproxen is cleared…
Genetik -
small molecule | CAS: 385800-16-8

Naproxen etemesil has been used in trials studying the treatment of Osteoarthritis.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech | CAS: 676258-98-3

Naptumomab Estafenatox has been used in trials studying the treatment of Pancreatic Cancer, Renal Cell Carcinoma, and Non-Small-Cell Lung Carcinoma.

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesBiological Factors +8
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Naquotinib DB12036
small molecule | CAS: 1448232-80-1

Naquotinib has been used in trials studying the treatment of Solid Tumors, Non-small Cell Lung Cancer, Non-Small-Cell Lung Cancer (NSCLC), Epidermal Growth Factor Receptor Mutations, and Epidermal Growth Factor Receptor (EGFR) Mutations, among others.

Kategori:
Antineoplastic AgentsEnzyme InhibitorsProtein Kinase Inhibitors
Target Protein:
Epidermal growth factor receptor
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Narasin DB11432
small molecule | CAS: 55134-13-9

Narasin is an agent with coccidiostatic and antibacterial properties.

Kategori:
Anti-Bacterial AgentsAnti-Infective AgentsAntiparasitic Agents +3
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Naratriptan Approved DB00952
small molecule | CAS: 121679-13-8

Naratriptan is a triptan drug that is selective for the 5-hydroxytryptamine1 receptor subtype. It is typically used for the treatment of migraine headaches.

Kategori:
Agents that produce hypertensionAminesAnalgesics +23
Target Protein:
5-hydroxytryptamine receptor 1A5-hydroxytryptamine receptor 1D5-hydroxytryptamine receptor 1B +1
Gen Terkait:
GNB3
Waktu Paruh5-8 hours
Vol. Distribusi* 170 L
Klirens* 6.6 mL/min/kg
Genetik 1 Varian
biotech | CAS: 1607824-64-5

Naratuximab emtansine is under investigation in clinical trial NCT01534715 (IMGN529 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia).

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntibodies, Monoclonal +7
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Narazaciclib DB19038
small molecule | CAS: 1357470-29-1

Narazaciclib is under investigation in clinical trial NCT06351644 (On 123300 (Narazaciclib) and Dexamethasone in Patients With Relapsed And/or Refractory Multiple Myeloma).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech

Nardostachys chinensis whole is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Naringin DB16859
small molecule | CAS: 10236-47-2

Deskripsi belum tersedia.

Kategori:
BenzopyransChromonesFlavonoids +2
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Narlaprevir DB14760
small molecule | CAS: 865466-24-6

Deskripsi belum tersedia.

Kategori:
AmidesAmino AcidsAmino Acids, Branched-Chain +6
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Narlumosbart DB19002
biotech | CAS: 2646587-68-8

Narlumosbart is under investigation in clinical trial NCT06314698 (Narlumosbart Compared With Denosumab in Patients With Multiple Myeloma Bone Disease).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Narmafotinib DB18463
small molecule | CAS: 1393653-34-3

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Narnatumab DB14964
biotech | CAS: 1188275-92-4

Narnatumab is under investigation in clinical trial NCT01119456 (A Study of IMC-RON8 in Advanced Solid Tumors).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Naronapride DB05542
small molecule | CAS: 860174-12-5

Deskripsi belum tersedia.

Kategori:
Acids, CarbocyclicAmidesAntidepressive Agents +7
Target Protein:
5-hydroxytryptamine receptor 4
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Narsoplimab DB16418
biotech | CAS: 2108782-45-0

Thrombotic microangiopathies (TMA), including thrombotic thrombocytopenic purpura and atypical hemolytic uremic syndrome, are associated with injury and dysregulation of microvascular endothelium and platelets.[A241030] Evidence increasingly points to a role …

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntibodies, Monoclonal +6
Target Protein:
Mannan-binding lectin serine protease 2
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
NasoVAX DB15859
biotech

NasoVAX contains replication-deficient adenovirus vectors in suspension. It is a vaccine administered through a nasal spray that expresses influenza hemagglutinin in nasal epithelial cells[L16313]. Created by Altimmune, Inc., NasoVAX is currently being devel…

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Natalizumab Approved DB00108
biotech | CAS: 189261-10-7

Natalizumab is a recombinant humanized IgG4? monoclonal antibody that binds to ?4-integrin.[L48041] While natalizumab was originally approved by the FDA to treat multiple sclerosis in 2004, it was withdrawn from the market following multiple reports of fatal …

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntibodies, Monoclonal +14
Target Protein:
Integrin alpha-4Low affinity immunoglobulin gamma Fc region receptor III-BHigh affinity immunoglobulin gamma Fc receptor I +1
Waktu ParuhFollowing the repea…
Vol. DistribusiFollowing the repea…
KlirensFollowing the repea…
Genetik -
Natamycin Approved DB00826
small molecule | CAS: 7681-93-8

Amphoteric macrolide antifungal antibiotic from Streptomyces natalensis or S. chattanoogensis. It is used for a variety of fungal infections, mainly topically. [PubChem]

Kategori:
Alimentary Tract and MetabolismAnti-Bacterial AgentsAnti-Infective Agents +16
Target Protein:
Ergosterol
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Nattokinase DB15329
biotech | CAS: 133876-92-3

Nattokinase is under investigation in clinical trial NCT00749801 (Efficacy and Safety of Geneferm Nattokinase).

Kategori:
EndopeptidasesEnzymesEnzymes and Coenzymes +5
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech

Natural Killer (NK) cells originate and differentiate from hematopoietic stem cells through various signalling pathways involving cytokines and interleukins. These cells arise from CD34+ lymphoid progenitors and comprise 10-15% of all lymphocytes in human per…

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Menampilkan 9651–9700 dari 14063
Sebelumnya Halaman 194 / 282 Berikutnya